Tofacitinib
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Tofacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Tofacitinib is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $73.67 to $207.88 per EA — the most expensive product costs about 2.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$73.67 – $207.88
per EA
7d Activity
avg -0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TOFACITINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XELJANZ XR 11 MG TABLET | $207.8806 per EA | +0.01% |
XELJANZ 10 MG TABLET | $103.9384 per EA | +0.03% |
XELJANZ 5 MG TABLET | $73.6658 per EA | -0.09% |
Frequently Asked Questions
What is Tofacitinib used to treat?
Tofacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How many Tofacitinib products are on the market?
The Tofacitinib drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Tofacitinib?
NADAC reference prices for Tofacitinib range from $73.6658 to $207.8806 per EA — the most expensive product costs about 2.8× the cheapest.
Which manufacturers make Tofacitinib?
1 manufacturer lists Tofacitinib in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (3).
How has the price of Tofacitinib changed recently?
Over the past 7 days, 2 Tofacitinib NDCs rose and 1 fell, with a market-wide average change of -0.0%.